Literature DB >> 10886215

A novel BCR-ABL transcript (e8a2) with the insertion of an inverted sequence of ABL intron 1b in a patient with Philadelphia-positive chronic myeloid leukaemia.

S Branford1, Z Rudzki, T P Hughes.   

Abstract

An atypical BCR-ABL transcript in a patient with Philadelphia (Ph)-positive chronic myeloid leukaemia (CML) was detected using a long polymerase chain reaction technique. Sequence analysis revealed a joining of BCR exon e8 and ABL exon a2, with a 55-base pair (bp) insert of an inverted sequence of ABL intron 1b between them, giving rise to an in frame e8a2 BCR-ABL transcript. This is the first report of a BCR-ABL transcript with the insertion of an inverted sequence. The long PCR technique is a useful screen for atypical BCR-ABL transcripts not detected by standard techniques.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10886215     DOI: 10.1046/j.1365-2141.2000.02042.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  9 in total

1.  Comprehensive characterization of a novel intronic pseudo-exon inserted within an e14/a2 BCR-ABL rearrangement in a patient with chronic myeloid leukemia.

Authors:  Nathalie Sorel; Caroline Mayeur-Rousse; Séverine Deverrière; Lydia Roy; Elisabeth Brottier-Mancini; François Guilhot; Ali G Turhan; Jean Claude Chomel
Journal:  J Mol Diagn       Date:  2010-05-27       Impact factor: 5.568

2.  Novel BCR-ABL1 fusion and leukemic mutations of SETBP1, PAX5, and TP53 detected by next generation sequencing in chronic myeloid leukemia.

Authors:  Shuang Fu; Yanping Hu; Yu Fu; Fang Chen; Xuan Liu; Minyu Zhang; Xiaohui Wang; Shichun Tu; Jihong Zhang
Journal:  Cancer Biol Ther       Date:  2016-09-10       Impact factor: 4.742

3.  Analysis of the clinico-hematological relevance of the breakpoint location within M-BCR in chronic myeloid leukemia.

Authors:  Ayda Bennour; Ines Ouahchi; Bechir Achour; Monia Zaier; Yosra Ben Youssef; Abderrahim Khelif; Ali Saad; Halima Sennana
Journal:  Med Oncol       Date:  2012-12-27       Impact factor: 3.064

4.  A novel BCR-ABL1 fusion gene identified by next-generation sequencing in chronic myeloid leukemia.

Authors:  Xiaodong Lyu; Jingke Yang; Xianwei Wang; Jieying Hu; Bing Liu; Yu Zhao; Zhen Guo; Bingshan Liu; Ruihua Fan; Yongping Song
Journal:  Mol Cytogenet       Date:  2016-06-27       Impact factor: 2.009

Review 5.  Fusion transcripts: Unexploited vulnerabilities in cancer?

Authors:  Carla Neckles; Soumya Sundara Rajan; Natasha J Caplen
Journal:  Wiley Interdiscip Rev RNA       Date:  2019-08-13       Impact factor: 9.957

6.  A case report of pediatric acute lymphoblastic leukemia with e8a2 BCR/ABL1 fusion transcript.

Authors:  Aleksandra Mroczkowska; Bożena Jaźwiec; Justyna Urbańska-Rakus; Sylwia Szymanowska; Anna Tessmann; Sonia Pająk; Katarzyna Machnik; Olga Haus; Tomasz Wróbel
Journal:  BMC Med Genomics       Date:  2022-02-05       Impact factor: 3.063

7.  Atypical presentation of patients with chronic myeloid leukemia in chronic phase-Case report.

Authors:  Florian Ramdohr; Alice Fabarius; Bettina Maier; Daniela Bretschneider; Anna Jauch; Astrid Monecke; Klaus H Metzeler; Johannes W G Janssen; Richard F Schlenk; Sabine Kayser
Journal:  Front Oncol       Date:  2022-08-29       Impact factor: 5.738

8.  A 76-kb duplicon maps close to the BCR gene on chromosome 22 and the ABL gene on chromosome 9: possible involvement in the genesis of the Philadelphia chromosome translocation.

Authors:  Giuseppe Saglio; Clelia T Storlazzi; Emilia Giugliano; Cecilia Surace; Luisa Anelli; Giovanna Rege-Cambrin; Antonella Zagaria; Antonio Jimenez Velasco; Anabel Heiniger; Patrizia Scaravaglio; Antoni Torres Gomez; José Roman Gomez; Nicoletta Archidiacono; Sandro Banfi; Mariano Rocchi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-11       Impact factor: 11.205

9.  Optimal Response in a Patient With CML Expressing BCR-ABL1 E6A2 Fusion Transcript With Nilotinib Therapy: A Case Report.

Authors:  Livia Manzella; Elena Tirrò; Silvia Rita Vitale; Adriana Puma; Maria Letizia Consoli; Loredana Tambè; Maria Stella Pennisi; Sandra DI Gregorio; Chiara Romano; Cristina Tomarchio; Francesco DI Raimondo; Fabio Stagno
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.